SLNO logo

Soleno Therapeutics (SLNO) Depreciation And Amortization

Annual D&A

$1.96 M
-$6000.00-0.31%

December 31, 2023


Summary


Performance

SLNO Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$500.00 K
+$6000.00+1.21%

September 30, 2024


Summary


Performance

SLNO Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$1.97 M
+$10.00 K+0.51%

September 30, 2024


Summary


Performance

SLNO TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

SLNO Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.3%+2.0%+0.8%
3 y3 years+0.2%+2.0%+0.8%
5 y5 years-0.3%+2.0%+0.8%

SLNO Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.3%at lowat high+2.5%at high+0.8%
5 y5-year-0.3%+0.2%at high+2.5%at high+1.0%
alltimeall time-0.3%>+9999.0%-14.1%+1236.4%-4.0%>+9999.0%

Soleno Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$500.00 K(+1.2%)
$1.97 M(+0.5%)
Jun 2024
-
$494.00 K(+0.8%)
$1.96 M(+0.3%)
Mar 2024
-
$490.00 K(+0.2%)
$1.96 M(0.0%)
Dec 2023
$1.96 M(-0.3%)
$489.00 K(-0.2%)
$1.96 M(+0.1%)
Sep 2023
-
$490.00 K(+0.2%)
$1.96 M(-0.1%)
Jun 2023
-
$489.00 K(-0.2%)
$1.96 M(-0.2%)
Mar 2023
-
$490.00 K(+0.4%)
$1.96 M(-0.1%)
Dec 2022
$1.96 M(+0.1%)
$488.00 K(-0.8%)
$1.96 M(-0.2%)
Sep 2022
-
$492.00 K(0.0%)
$1.97 M(0.0%)
Jun 2022
-
$492.00 K(0.0%)
$1.97 M(+0.1%)
Mar 2022
-
$492.00 K(0.0%)
$1.97 M(+0.2%)
Dec 2021
$1.96 M(+0.5%)
$492.00 K(0.0%)
$1.96 M(+0.2%)
Sep 2021
-
$492.00 K(+0.4%)
$1.96 M(+0.2%)
Jun 2021
-
$490.00 K(+0.2%)
$1.96 M(+0.1%)
Mar 2021
-
$489.00 K(+0.2%)
$1.95 M(0.0%)
Dec 2020
$1.95 M(-0.2%)
$488.00 K(-0.2%)
$1.95 M(-0.1%)
Sep 2020
-
$489.00 K(+0.2%)
$1.96 M(-0.1%)
Jun 2020
-
$488.00 K(-0.2%)
$1.96 M(-0.1%)
Mar 2020
-
$489.00 K(-0.2%)
$1.96 M(0.0%)
Dec 2019
$1.96 M(-0.3%)
$490.00 K(0.0%)
$1.96 M(0.0%)
Sep 2019
-
$490.00 K(+0.2%)
$1.96 M(0.0%)
Jun 2019
-
$489.00 K(0.0%)
$1.96 M(-0.1%)
Mar 2019
-
$489.00 K(-0.2%)
$1.96 M(-0.2%)
Dec 2018
$1.96 M
$490.00 K(0.0%)
$1.96 M(-4.5%)
DateAnnualQuarterlyTTM
Sep 2018
-
$490.00 K(-0.2%)
$2.06 M(+1.5%)
Jun 2018
-
$491.00 K(-0.2%)
$2.02 M(+2.0%)
Mar 2018
-
$492.00 K(-15.5%)
$1.98 M(+23.2%)
Dec 2017
$1.61 M(+8515.0%)
$582.00 K(+26.8%)
$1.61 M(+53.9%)
Sep 2017
-
$459.00 K(+1.8%)
$1.05 M(+92.5%)
Jun 2017
-
$451.00 K(+279.0%)
$543.70 K(+361.9%)
Mar 2017
-
$119.00 K(+572.3%)
$117.70 K(+529.4%)
Dec 2016
$18.70 K(-82.7%)
$17.70 K(-140.2%)
$18.70 K(-62.7%)
Sep 2016
-
-$44.00 K(-276.0%)
$50.20 K(-58.9%)
Jun 2016
-
$25.00 K(+25.0%)
$122.20 K(+8.0%)
Mar 2016
-
$20.00 K(-59.3%)
$113.20 K(+4.6%)
Dec 2015
$108.20 K(+279.6%)
$49.20 K(+75.7%)
$108.20 K(+60.3%)
Sep 2015
-
$28.00 K(+75.0%)
$67.50 K(+48.4%)
Jun 2015
-
$16.00 K(+6.7%)
$45.50 K(+24.7%)
Mar 2015
-
$15.00 K(+76.5%)
$36.50 K(+28.1%)
Dec 2014
$28.50 K(-32.3%)
$8500.00(+41.7%)
$28.50 K(-5.3%)
Sep 2014
-
$6000.00(-14.3%)
$30.10 K(-15.9%)
Jun 2014
-
$7000.00(0.0%)
$35.80 K(-6.5%)
Mar 2014
-
$7000.00(-30.7%)
$38.30 K(-9.0%)
Dec 2013
$42.10 K(-3.9%)
$10.10 K(-13.7%)
$42.10 K(+31.6%)
Sep 2013
-
$11.70 K(+23.2%)
$32.00 K(+57.6%)
Jun 2013
-
$9500.00(-12.0%)
$20.30 K(+88.0%)
Mar 2013
-
$10.80 K
$10.80 K
Dec 2012
$43.80 K
-
-

FAQ

  • What is Soleno Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Soleno Therapeutics?
  • What is Soleno Therapeutics annual D&A year-on-year change?
  • What is Soleno Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly D&A year-on-year change?
  • What is Soleno Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Soleno Therapeutics?
  • What is Soleno Therapeutics TTM D&A year-on-year change?

What is Soleno Therapeutics annual depreciation & amortization?

The current annual D&A of SLNO is $1.96 M

What is the all time high annual D&A for Soleno Therapeutics?

Soleno Therapeutics all-time high annual depreciation & amortization is $1.96 M

What is Soleno Therapeutics annual D&A year-on-year change?

Over the past year, SLNO annual depreciation & amortization has changed by -$6000.00 (-0.31%)

What is Soleno Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of SLNO is $500.00 K

What is the all time high quarterly D&A for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly depreciation & amortization is $582.00 K

What is Soleno Therapeutics quarterly D&A year-on-year change?

Over the past year, SLNO quarterly depreciation & amortization has changed by +$10.00 K (+2.04%)

What is Soleno Therapeutics TTM depreciation & amortization?

The current TTM D&A of SLNO is $1.97 M

What is the all time high TTM D&A for Soleno Therapeutics?

Soleno Therapeutics all-time high TTM depreciation & amortization is $2.06 M

What is Soleno Therapeutics TTM D&A year-on-year change?

Over the past year, SLNO TTM depreciation & amortization has changed by +$16.00 K (+0.82%)